Editorial & Columns Higher return on gold investment instead of equity March 19, 2025 | Satish Singh | No Comments | More
Editorial & Columns War Clouds on the Horizon: Pak’s Civil War Endangers Peace in the Region March 18, 2025 | Gopal Misra | No Comments | More
Editorial & Columns On the Right Side of Regulations: The USFDA and Indian Pharmaceutical Companies March 12, 2025 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Challenging Corruption: Modi Hesitates, but Trump Picks up the Gauntlet March 12, 2025 | Gopal Misra | No Comments | More
Editorial & Columns Be Cautious, while using Messaging Apps and social media March 10, 2025 | Satish Singh | No Comments | More
Editorial & Columns Heal Pharma: Restore trust in India’s medicine March 8, 2025 | Abdul Wasey | No Comments | More
Editorial & Columns Stock Market-No need of panic, recover soon March 8, 2025 | Satish Singh | No Comments | More
Editorial & Columns CSR by Pharmaceutical Companies and Engagement with SHGs, NGOs & Foundations March 6, 2025 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Investors in Panic: Hold or Sell? March 5, 2025 | Narvijay Yadav | No Comments | More
Editorial & Columns India is Worried: US-Ukraine May Sign Agreement for Minerals March 5, 2025 | Gopal Misra | No Comments | More